Background stories of how others approached and experienced their European Horizon funding trajectory.
Published on | 2 months ago
Programmes HealthThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
Read the full article for detailsThe MareGraph project, ‘Towards an Interoperable Marine Knowledge Graph’, obtained funding under the Digital Europe topic ‘OPEN-AI – Public Sector Open Data for AI and Open Data Platform’. The project will increase the semantic, technical, and legal interoperability of three selected high-valued datasets (HVDs) all maintained by the Flanders Marine Institute (VLIZ), which is one of the four partners of the project. This will allow the onboarding of essential marine datasets in the Common European Data Spaces. As such MareGraph will provide a structural component in the digital transition of the marine landscape. The numerous impacts of the project will benefit our seas globally in old and new ways to come.